Silvia Capuani1,2, Roberto Coccurello3, Riccardo De Feo4, Lorenzo Rossi5, Giulia Tuttobene5, Emanuele Agrimi5, Clelia Raso5, Federico Giove2,4, and Umberto Tarantino6
1Physics Dpt Sapienza, CNR ISC, Rome, Italy, 2Santa Lucia foundation, Rome, Italy, 3CNR ISC, Rome, Italy, 4Museo Storico della Fisica e Centro Studi e Ricerche Enrico Fermi, Rome, Italy, 5Physics Dpt., Sapienza University, Rome, Italy, 6Tor Vergata University, PTV, Rome, Italy
Synopsis
Aim
of this study was to identify relevant changes in the metabolic profile of
bone-marrow and muscle during healthy aging in both men and women. Towards this
goal, single-voxel MRS with STEAM at TE=6ms and T2 evaluation of each resonance
was performed. Bone-marrow fatty-acids quantification show a clear sex
dimorphism with normal aging while no significant differences were found in the
muscle metabolites of female and male subjects. On the other hand, metabolite-T2
values were different in male and female resonances and significant T2
differences among 36+, 36-52 and 52+ group, finding higher T2 in older group
were observed.
Introduction
Aging
is associated with both losses of bone mineral density (BMD) and increased fracture risk (i.e.,
osteoporosis) and sarcopenia (i.e., loss of muscle strength and mass). There is
now growing evidence that the mechanical/endocrine relationship and the
bidirectional communication between muscle and bone can determine the impact of
aging and the severity of the decline in muscle size and bone fragility. Moreover,
there is increasing evidence that age-associated changes in body composition may
severely affect fat tissue and adipose1,2 In this view, 1H-MRS is an
excellent tool for investigating muscle3 and has proved to be a useful tool for
investigating bone quality through the quantification of bone marrow fatty
acids4. The aim of this study was to identify relevant changes in the metabolic
profile of bone-marrow and muscle during healthy aging in both men and women. A
better understanding of the bone-muscle connection, and gender-associated
differences, via the alterations of selected fatty-acids, may pave the way for novel
medical interventions in musculoskeletal diseases such as sarco-osteoporosis.Methods
Thirty-two
Caucasian subjects (age range 18-82 years, 18 female, 14 male) were recruited
to investigate tibial bone-marrow and soleus/gastrocnemius muscle. Subjects
were excluded in the case of clinical evidence for metabolic bone disease or
metastasis, previous history of irradiation, and current use of steroids or
hormone replacement therapy. From each volunteer, clinical data (age, sex, body-mass-index, BMD) were collected. The study was approved
by the Local Ethics Committee. Written informed consent was obtained from each
subject before the MRS-examination. Experiments: Single-voxel-MRS was performed by STEAM
sequence with TE=6ms. Specifically, 20x20x30mm3 voxel-size, acquired
with VAPOR sequence, NS=48, TR=5s, TE=6,35,135ms were used to obtain muscle-spectra
and to evaluate the T2 of each resonance. A 8x8x30mm3 voxel-size, NS=32,
TR=5s, TE=6,35,60ms were used to obtain bone-marrow-spectra and to evaluate T2
of each resonance. Processing and statistical analysis: Row data of spectra
acquired from each subject were analyzed using LcModel software5 (SPTYPE 6).
Zero and first-order phase-corrections were performed. Nine proton-resonances were
quantified in bone-marrow spectra: CH3 (labeled L09, at 0.90ppm), bulk-CH2 (L13
at 1.3ppm), CH2α- (L23 at 2.3ppm) and β- (L16 at 1.59ppm) to the carbonyl,
allylic-CH2 α to a double-bound (L21 at 2.03ppm), water (W at 4.7ppm), glycerol CH2, glycerol CH (L41+L43 at
4.10-4.35ppm) and olefinic double-bond protons (L52+L53 at 5.20ppm). Moreover,
from muscle-spectra we quantified: Intramyocellular lipids (IMCL at 1.3ppm),
extramyocellular lipids (EMCL at 1.5ppm), creatine (Cr at 3.0ppm), choline (Cho at 3.2ppm), taurine, and other fatty-acids
resonances. Each bone-marrow and muscle resonance was computed as mean±SD. Data
with a %SD equal to or higher than 10% were discarded.T2 of each resonance was
calculated. Each resonance area obtained at TE=6ms was corrected for its T2
value. Homogeneity of variances between
groups (subjects with age less than 36y, 36-, from 36 to 52y, 36-52, and higher
than 52y, 52+, female and male) was tested by Levene’s test. Pairwise comparisons
between groups were made using a Welch ANOVA. Games-Howell corrections were
performed to correct for multiple testing. Pearson correlation was studied
between fatty acids/ metabolites and age.Results
Examples of
tibial bone-marrow spectrum and soleus/gastrocnemius muscles spectrum are
displayed in Fig.1 and Fig.2, respectively.
Bone-marrow: a negative-significant correlation was found between L53+L52
(unsaturated fat) and age (r=-0.57, p=0.02) and between L16+L13 and age
(r=-0.60, p=0.01) in female-group. L16+L13 discriminates between 36- and 36-52
female-group, and 36- and 52+ female-group. No-significant mean values metabolites
differences and correlation with age were found in the male-group. No-significant
difference of mean T2 was found between male and female and among age-range
groups.
Muscle: No-significant differences were found between fatty-acids and metabolites of males
and females. Regarding the global (female+male-group) correlation with age, a significant correlation was found between
EMCL15, E11, E55, I55+E55, I21 and age (Table 1, Fig.3). Cr-T2
and Cho-T2 significantly discriminate between 36- and 36-52, 52+. In general
resonances-T2 of the female-group are longer than those of the male-group in all muscle
resonances. Differently from literature, no significant correlation was found
between IMCL, Cr, Cho, and age but we found (except for EMCL) significant T2
differences among 36+, 36-52, and 52+ group, finding higher T2 in the older group.Discussion
Bone-marrow
fatty-acids quantification shows a clear sexual dimorphism with normal aging while
no significant differences were found in the muscle metabolites of female and male subjects. Therefore,
the observed bone-marrow fatty-acids differences during normal aging appear to
be more closely related to BMD than to muscle metabolism. Muscle EMCL increases
with age while IMCL remains constant. However, while the T2 values of EMCL are
constant during aging, those of the IMCL show significant differences between
age groups, increasing with age. As T2 is related to cell density, the results
are compatible with cell microstructure degradation.Conclusions
Single-voxel-MRS
and T2 measurements of metabolites in human legs could be useful for evaluating
biomarkers of normal aging and sex dimorphism in the musculoskeletal system. This
work suggests that instead of looking only at metabolite concentrations, tissue
integrity should also be assessed with age. Indeed, any changes in metabolite
concentrations may be due not so much to global changes as to a local
microstructural variation in the tissues in which the metabolite is quantified.Acknowledgements
This work was supported by CNCCS Consortium References
1. Giulia Di Pietro, Manuel Scimeca, Riccardo Iundusi, Monica Celi, Elena Gasbarra, Umberto Tarantino, Silvia Capuani. Differences between muscle from osteoporotic and osteoarthritic subjects: in vitro study by diffusion-tensor MRI and histological findings. Aging Clinical and Experimental Research (2020) 32; 2489–2499.
2. Christian Cordes, Thomas Baum, Michael Dieckmeyer, Stefan Ruschke, Maximilian N. Diefenbach, Hans Hauner, Jan S. Kirschke and Dimitrios C. Karampinos. MR-Based Assessment of Bone Marrow Fat in Osteoporosis, Diabetes, and Obesity Front. Endocrinol. (2016) 7:74.
3. Laura M. Fayad, Nouha Salibi, Xin Wang, Antonio J. Machado, Michael A. Jacobs, Ronald Ouwerkerk, Baasile Okollie, David A.
Bluemke, John Eng, and Peter B. Barker. Quantification of Muscle Choline Concentration by Proton MR
Spectroscopy at 3 Tesla: Technical Feasibility. Am J Roentgenol. (2010) 194(1): W73–W79
4. Giulia Di Pietro, Silvia Capuani, Guglielmo Manenti, Vincenzo Vinicola, Armando Fusco, Jacopo Baldi, Manuel Scimeca, Gisela Hagberg, Marco Bozzali, Giovanni Simonetti, Umberto Tarantino. Bone marrow lipid profiles from peripheral skeleton as potential biomarkers for osteoporosis: a 1H-MR spectroscopy study. Academic Radiology (2016) 23(3);273-283.
5. Provencher, S. W. Estimation of metabolite concentrations
from localized in vivo proton NMR spectra. Magn Reson Med (1993) 30,
672–679.